Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Affirming support for most-favored-Nation drug pricing for United States patients. H. Res. 928. 119th Cong., 1st sess., Introduced in House December 4, 2025. https://www.govinfo.gov/app/details/BILLS-119hres928ih.
Congress, House of Representatives (2025, December 4). Affirming support for most-favored-Nation drug pricing for United States patients. (H. Res. 928 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hres928ih.
United States, Congress, House of Representatives. Affirming support for most-favored-Nation drug pricing for United States patients. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hres928ih. 119th Congress, H. Res. 928, Introduced in House 4 Dec. 2025.
H.Res.928 - 119th Congress (2025-2026): Affirming support for most-favored-Nation drug pricing for United States patients., H.Res.928, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hres928ih.